Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children (COENZYME)

Central Hospital, Nancy, France

Status: Completed

Conditions: Cyclic Vomiting Syndrome

Treatments: Drug: Q10 Coenzyme

Study type: Observational

Funder types: Other

Identifiers

NCT03295760

PSS2016/COENZYME-FEILLET/VS

Details and patient eligibility

About

The main purpose of this study is the comparison of frequency of vomiting episodes (number of episodes per year) observed during the year after the begin of Q10 coenzyme treatment to frequency observed during the year before the begin of this treatment in children with cyclic vomiting syndrome.

Secondary purposes are the evaluation of life quality of parents and children, of treatment safety and its economic cost compared to other recommended treatments.

Enrollment: 15 patients

Sex: All

Ages: Under 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Cyclic vomiting syndrome as defined by Rome IV criteria
• Treated with Q10 coenzyme treatment for cyclic vomiting syndrome
• Q10 coenzyme treatment started between January 2000 and July 2006

Exclusion criteria

• Refusal of processing of personal data reported in patient medical files

Trial design

15 participants in 1 patient group

Children with cyclic vomiting syndrome

Description:

Children followed at Children's Hospital of Nancy treated with Q10 coenzyme for cyclic vomiting syndrome

Treatment:

Drug: Q10 Coenzyme